Skip to main content
SHINIL PHARMACEUTICAL CO., LTD. logo

SHINIL PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 012790 ISIN · KR7012790002 KO Manufacturing
Open in API
Filings indexed 198 across all filing types
Latest filing 2021-12-22 Director's Dealing
Country KR South Korea
Listing KO 012790

About SHINIL PHARMACEUTICAL CO., LTD.

https://shinilpharma.com/

SHINIL PHARMACEUTICAL CO., LTD. is a drug manufacturing company that develops, produces, and sells a diverse range of pharmaceutical products. The company's portfolio encompasses various therapeutic areas, including vitamins, mineral supplements, anti-inflammatory enzymes, antihistamines, appetite stimulants, and treatments for liver disease. Its product offerings also include topical medications such as gels and medicated plasters. The company serves both domestic and international markets.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean regulatory authorities. This type of filing details personal share transactions, changes in ownership, and holdings by company directors or major shareholders. According to the provided definitions, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing' (DIRS).
2021-12-22 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Shinil Pharmaceutical regarding the decision to pay a cash dividend. It specifies the dividend amount per share, the total dividend amount, the record date, and the expected payment date. This aligns perfectly with the definition of a 'Notice of Dividend Amount' (DIV).
2021-12-20 Korean
주식배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Shinil Pharmaceutical regarding a decision to issue stock dividends. It specifies the number of shares per dividend, the total number of shares to be issued, the dividend record date, and the board resolution date. This falls under the category of dividend announcements, which is specifically covered by the 'DIV' code.
2021-12-20 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a formal notice from Shinil Pharmaceutical regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the 45th Annual General Meeting. This type of regulatory disclosure, which informs shareholders of upcoming meeting-related administrative actions, is classified as a general regulatory filing under the RNS category as it does not fit into specific categories like dividend announcements or proxy solicitations.
2021-12-14 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 100% confidence The document is a regulatory announcement from Shinil Pharmaceutical regarding the determination of a record date for shareholder registry closure for the purpose of potential cash/in-kind dividends. It is a formal corporate disclosure regarding dividend-related administrative procedures, which falls under the category of dividend announcements.
2021-12-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is specifically used to report insider transactions, such as share disposals or acquisitions by directors and major shareholders. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS).
2021-12-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.